Skip to main content
. Author manuscript; available in PMC: 2014 Jun 21.
Published in final edited form as: JAMA Neurol. 2013 Dec;70(12):1566–1568. doi: 10.1001/jamaneurol.2013.3205

Table.

Antibody Titers Measured Using Serial Dilutions of Serum or Cerebrospinal Fluid and Cell-Based Assay

Time After Hospital Admission, mo Summary of All Treatment Modalities and Antibody Titers Serum Antibodya CSF Antibodya
1 Diagnostic lumbar puncture 1:102 400 1:10 240
1.5 Teratoma resection and oophorectomy
2 IVIg
2 Methylprednisolone
2–3 Rituximab
4 Diagnostic lumbar puncture 1:51 200 1:5120
6, 7, and 8 Cyclophosphamide
8–9 Rituximab
10 Diagnostic lumbar puncture 1:25 600 1:2560
11 Cyclophosphamide
12 Plasmapheresis
12 Diagnostic lumbar puncture 1:51 200 1:5120
13–16 Intravenous high-dose methotrexate
16 Rituximab
16 Diagnostic lumbar puncture 1:25 600 1:5120
18 Electroconvulsive shock
20 Cyclophosphamide
20 IVIg
22 Cyclophosphamide
22 IVIg

Abbreviations: CSF, cerebrospinal fluid; IVIg, intravenous immunoglobulin.

a

Antibody titers were determined using serial dilutions of serum and CSF on rat brain tissue and human embryonic kidney cells expressing NR1 subunits of the N-methyl-D-aspartate receptor. The titer reflects the highest dilution at which reactivity was visible.